May 21, 2024

Autologous Stem Cell and Non-Stem Cell Based Therapies Market is Estimated to Witness High Growth Owing to Increased investments in R&D

Autologous stem cell and non-stem cell based therapies involve the isolation and purification of patient’s own stem cells for treating various diseases and injuries. These therapies are used for treating orthopedic, cardiovascular, neurological disorders among others.

Market Dynamics:

The autologous stem cell and non-stem cell based therapies market is witnessing high growth owing to increased investments in R&D of regenerative medicines and stem cell therapies. Major players are investing significantly in developing advanced cell processing facilities and technologies. Furthermore, increasing prevalence of chronic diseases such as cancer, cardiovascular diseases and neurological disorders is also driving the demand for stem cell therapies globally. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Stem cell therapies offer novel treatment options for such chronic and degenerative diseases.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Market Drivers

Increasing prevalence of cancer and other chronic diseases

The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, neurological disorders and other autoimmune conditions is playing a key role in fuelling the autologous stem cell and non-stem cell based therapies market. Stem cell therapies are being extensively researched upon as a potential form of treatment for various chronic illnesses. According to WHO, cancer burden is expected to grow to 22 million new cases per year by 2030. Stem cell therapies offer hope in treating various cancer types more effectively with minimal side effects.

Growing research into regenerative medicine applications and favorable regulatory scenario

Significant investments are being made by government as well as private players in conducting research related to regenerative medicine applications of stem cells. Initiatives like 21st Century Cures Act are boosting research activities. Many regional regulatory agencies are also promoting clinical trials of autologous stem cell therapies. For instance, U.S. FDA has approved a large number of cell and gene therapy products in recent years. Further, the European Medicines Agency (EMA) has also adopted a positive approach towards the development of innovative therapies. This favorable regulatory environment is fueling the market growth.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Market Restrain

High costs associated with stem cell therapies

A major restraint to the adoption of autologous stem cell therapies has been the high costs associated with development as well as treatment procedures. Stem cell research and production of innovative stem cell-based treatment options require huge investments of time and capital. Further, the complex nature of these therapies translates to high costs which are generally not completely covered by the average medical insurance. This makes these therapies unaffordable for a large section of patient population globally. The high costs pose significant pricing challenges especially in developing economies.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Market Opportunity

Increasing focus on development of personalized medicines

One of the prominent trends in the pharmaceutical industry is the shift towards more targeted and customized treatment approaches. Stem cell therapies have potential to truly revolutionize the paradigm of personalized medicines. The ability of these cells to turn into various cell types enables development of patient-specific treatments. Researchers are exploring possibilities of using stem cells to model patients’ condition for better understanding of disease pathology as well as efficacy of drugs. Leveraging such potential applications of stem cells provides huge opportunities for market players in the personalized medicines domain.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Trend

Rising focus on clinical applications of mesenchymal stem cells

Mesenchymal stem cells (MSCs) are being investigated extensively for disease modeling/drug discovery and cell-based therapies. MSCs have certain immunomodulatory properties which makes them suitable candidates for allogeneic stem cell transplantation as well. Further, these cells are available in abundance from various adult tissues such as bone marrow, adipose tissue and dental pulp. The ease of isolation procedures has propelled numerous clinical trials evaluating MSCs for treatment of conditions like graft-versus-host disease, pulmonary diseases and musculoskeletal disorders. Leveraging the potential of these multipotent stem cells presents a huge market opportunity.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it